Facebook
TwitterIt is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.
What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.
CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.
Facebook
Twitterhttps://www.marknteladvisors.com/privacy-policyhttps://www.marknteladvisors.com/privacy-policy
Global Cannabidiol Market size was valued at around USD 22.7 billion in 2023 and is projected to grow at a CAGR of around 19.21% during the forecast period 2024-30. increasing popularity of functional CBD products is one of the key trends shaping the growth of cbd market.
Facebook
TwitterSales of CBD products in the United States stood at **** billion U.S. dollars in 2022. By 2026, this market is expected to grow to **** billion dollars in value.
Facebook
Twitterhttps://www.technavio.com/content/privacy-noticehttps://www.technavio.com/content/privacy-notice
Cannabidiol (CBD) Market Size 2025-2029
The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.
The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.
What will be the Size of the Cannabidiol (CBD) Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.
Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.
The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.
How is this Cannabidiol (CBD) Industry segmented?
The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Source
Marijuana
Hemp
Distribution Channel
Offline
Online
End-user
Medical
Personal use
Wellness
Geography
North America
US
Canada
Mexico
Europe
France
Germany
UK
APAC
China
India
Japan
South Korea
Rest of World (ROW)
.
By Source Insights
The marijuana segment is estimated to witness significant growth during the forecast period.
CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product innovation.
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Facebook
Twitterhttps://straitsresearch.com/privacy-policyhttps://straitsresearch.com/privacy-policy
The global cannabidiol (CBD) market size is projected to grow from USD 13.14 billion in 2025 to USD 51.43 billion by 2033, exhibiting a CAGR of 18.6%.
Report Scope:
| Report Metric | Details |
|---|---|
| Market Size in 2024 | USD 11.08 Billion |
| Market Size in 2025 | USD 13.14 Billion |
| Market Size in 2033 | USD 51.43 Billion |
| CAGR | 18.6% (2025-2033) |
| Base Year for Estimation | 2024 |
| Historical Data | 2021-2023 |
| Forecast Period | 2025-2033 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Source Type,By Product Type,By Application,By Distribution Channel,By Region. |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM, |
| Countries Covered | U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Singapore, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia, |
Facebook
TwitterThe market for cannabidiol (CBD) in Canada was worth *** million U.S. dollars in 2022. By 2026, the market is expected to have grown to ***** million dollars.
Facebook
Twitterhttps://www.polarismarketresearch.com/privacy-policyhttps://www.polarismarketresearch.com/privacy-policy
Natural wellness revolution! $9.81B CBD market expanding across pharmaceuticals, beauty care & food. Uncover winning strategies from Aurora Cannabis, Canopy Growth & top innovators
Facebook
Twitterhttps://www.marknteladvisors.com/privacy-policyhttps://www.marknteladvisors.com/privacy-policy
Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.
Facebook
Twitterhttps://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
Europe CBD Product market size is USD 2344.56 million in 2024 and will expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.
Facebook
Twitterhttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).
Facebook
Twitterhttps://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
Discover the booming full-spectrum CBD market! Explore a $2.916 billion industry (2025) with a projected high CAGR, driven by pain relief, anxiety reduction, and more. Learn about key players, trends, and regional variations in this comprehensive market analysis. Invest wisely in this rapidly expanding sector.
Facebook
Twitterhttps://www.datainsightsmarket.com/privacy-policyhttps://www.datainsightsmarket.com/privacy-policy
The size of the CBD Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 10.00% during the forecast period. Recent developments include: April 2022: Hemp Bombs announced the launch of its newest offering Delts-9 THC Gummies which are available at selective retail locations and on online platforms., March 2022: Puration, Inc and PAO group Inc confirmed the two companies are working together on a new line of CBD nutraceuticals under PURA's Farmersville hemp brand name.. Key drivers for this market are: Increasing prevalence of Chronic diseases and related complications, Increasing awareness among the consumers regarding health. Potential restraints include: Strict regulation on the Cannabidiol products. Notable trends are: The Hemp Segment is Expected to Hold a Significant Share in the Cannabidiol (CBD) Market..
Facebook
Twitterhttps://www.promarketreports.com/privacy-policyhttps://www.promarketreports.com/privacy-policy
The size of the CBD Market was valued at USD 24.78 billion in 2023 and is projected to reach USD 78.47 billion by 2032, with an expected CAGR of 17.90% during the forecast period. Recent developments include: June 2021: For about USD 60 million, The Valens Company finalized the purchase of Green Roads. The acquisition provides The Valens Company with a well-established Green Road network that allows it access to the U.S. CBD industry., October 2020: Researchers and faculty at the Medical College of Georgia and the Dental College of Georgia have shown how cannabidiol (CBD) can cause significantly less lung damage and inflammation. They have also demonstrated how CBD can raise oxygen levels for disorders connected to adult respiratory problems.. Key drivers for this market are: Growing Research And Development Activities And Financial Support By Various Private And. Potential restraints include: Adverse Effects Associated With Cannabis 25, Stringent Government Policies 25. Notable trends are: Increasing the use of cannabidiol (CBD) for medicinal purposes will boost the market growth.
Facebook
Twitterhttps://www.statsndata.org/how-to-orderhttps://www.statsndata.org/how-to-order
The Hemp Source CBD market has emerged as a dynamic and rapidly evolving sector within the broader cannabis industry, capturing the attention of both consumers and investors alike. With its roots deeply embedded in the use of hemp-derived cannabidiol, or CBD, this market is driven by the versatile application of CBD
Facebook
Twitter
According to our latest research, the global CBD market size in 2024 stands at USD 8.2 billion, reflecting robust expansion driven by increasing consumer acceptance and adoption of cannabidiol-based products. The industry is experiencing a strong compound annual growth rate (CAGR) of 21.5% from 2025 to 2033. By the end of 2033, the CBD market is forecasted to reach a value of USD 57.1 billion. This impressive growth trajectory is primarily fueled by the rising demand for natural wellness products, expanding legalization across several countries, and ongoing research supporting the therapeutic benefits of CBD.
One of the key growth factors propelling the CBD market is the increasing awareness and acceptance of CBDÂ’s potential health benefits among consumers. As scientific research continues to validate the efficacy of CBD in managing various health conditions such as anxiety, chronic pain, inflammation, and epilepsy, consumers are increasingly turning to CBD as an alternative or complementary therapy. This shift in consumer behavior is further supported by educational initiatives from both governmental and private organizations, which are dispelling myths and misconceptions about CBD, leading to greater mainstream adoption. Additionally, the proliferation of information through digital platforms and social media has played a pivotal role in educating consumers about the safe and effective use of CBD products, thereby expanding the addressable market.
Another significant driver of the CBD market is the evolving regulatory landscape, particularly the gradual legalization and decriminalization of hemp-derived CBD products across major markets such as North America and Europe. The passage of the 2018 Farm Bill in the United States, which legalized the cultivation of industrial hemp and the extraction of hemp-derived CBD, has been a watershed moment for the industry. This regulatory shift has encouraged a wave of investments, innovation, and new product launches, as businesses seek to capitalize on the burgeoning demand for CBD-infused products. Moreover, the increasing clarity and harmonization of CBD regulations across regions are reducing barriers to entry, fostering cross-border trade, and enabling multinational companies to expand their footprint in the global CBD market.
The diversification of product offerings and the entry of established players from adjacent industries are also catalyzing market growth. The CBD market has evolved beyond traditional oils and tinctures to encompass a wide array of formats, including edibles, topicals, beverages, capsules, and even pet products. This product innovation is attracting a broader consumer base, including those who may have been hesitant to try CBD in its original forms. Furthermore, collaborations between CBD manufacturers and companies in the food, beverage, cosmetics, and pharmaceutical sectors are resulting in the development of novel products with enhanced efficacy and appeal. As a result, the CBD market is not only expanding in terms of volume but also in terms of consumer demographics and use cases, driving sustained growth over the forecast period.
From a regional perspective, North America continues to dominate the global CBD market, accounting for the largest share in terms of revenue and product innovation. The United States, in particular, is at the forefront, benefiting from a favorable regulatory environment, high consumer awareness, and a thriving ecosystem of manufacturers and distributors. Europe follows as the second-largest market, with countries such as the United Kingdom, Germany, and Switzerland witnessing increased legalization and consumer acceptance. Meanwhile, the Asia Pacific region is emerging as a high-growth market, driven by changing regulations, rising health consciousness, and increasing investments in research and development. Latin America and the Middle East & Africa are also showing promising growth potential, albeit from a smaller base, as regulatory frameworks evolve and consumer interest in natural wellness products rises.
Facebook
Twitterhttps://www.archivemarketresearch.com/privacy-policyhttps://www.archivemarketresearch.com/privacy-policy
Discover the booming Cannabidiol (CBD) ingredient market, projected to reach $20 billion by 2033! Explore market size, CAGR, key drivers, trends, restraints, and leading companies shaping this dynamic industry. Learn about the growth in CBD applications across food & beverage, cosmetics, nutraceuticals, and pharmaceuticals.
Facebook
Twitterhttps://www.reportsanddata.com/privacy-policyhttps://www.reportsanddata.com/privacy-policy
Cannabidiol (CBD) Market size was USD 5.9 Billion in 2022 and is expected to register a revenue CAGR of 17% during the forecast period.
Facebook
Twitterhttps://www.statsndata.org/how-to-orderhttps://www.statsndata.org/how-to-order
The Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market has emerged as a groundbreaking sector within the global wellness and pharmaceutical industries, driven by a surge in consumer interest and scientific research into the therapeutic benefits of cannabis-derived compounds. THC, the psychoactive component of c
Facebook
Twitterhttps://www.thereportcubes.com/privacy-policyhttps://www.thereportcubes.com/privacy-policy
Analyze the UK CBD Market rising from USD 0.89 Bn to USD 2.39 Bn by 2034 (11.6% CAGR). Unlock key trends and essential market insights for 2026-2034.
Facebook
TwitterIt is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.
What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.
CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.